News

The Therapies Experts Call the Biggest Breakthroughs in Decades

Sep 24, 2026

Drug Combination, Inluriyo + Verzenio, Offers Hope for ESR1 Mutated Breast Cancer Patients After Hormone Therapy Stops Working

Sep 23, 2026 in Breast Cancer

Updated Data Show Targeted Drug Ibtrozi Can Keep ROS1-Positive Lung Cancer Under Control For Longer

Sep 21, 2026 in Lung Cancer

ctDNA Surveillance Improves Early Detection of Colon Cancer Recurrence, and Experts Say Guidelines Lag Behind

Sep 21, 2026 in Colon Cancer

Prostate Cancer: Leading Oncologists Say Treatment Is Shifting Beyond a One-Size-Fits-All Approach Toward More Personalized Care

Sep 17, 2026

What Men Facing ‘Active Surveillance’ for Prostate Cancer Can Expect and Why

Sep 17, 2026 in Prostate Cancer

New Rybrevant Data Show Where the Drug May Fit Compared With Tagrisso

Sep 17, 2026 in Lung Cancer

Follicular Lymphoma: Moving Toward a Chemotherapy-Free Future

Sep 16, 2026

New Data Show Lung Cancer Treatment Gotistobart ‘Nearly Doubles Survival’ in Previously Treated Patients

Sep 15, 2026 in Lung Cancer

Allogene CEO Zach Roberts Is Pushing to Make CAR T-Cell Therapy More Accessible: 'That's What Gets Me Out of Bed'

Sep 9, 2026

'An Opportunity To Stay One Step Ahead': FDA Approves Camizestrant at First Sign of Treatment Resistance For Many With Advanced Breast Cancer

Sep 9, 2026 in Breast Cancer

Lung Cancer Treatment May Become More Adaptive With a Simple Blood Test

Sep 8, 2026